Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation
- 1 February 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (2) , 444-452
- https://doi.org/10.1016/s0360-3016(01)02598-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUESJournal of Urology, 2000
- PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2000
- The radial distance of extraprostatic extension of prostate carcinomaCancer, 1999
- HIGH DOSE COMBINATION RADIOTHERAPY FOR THE TREATMENT OF LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Treatment Options for Localized Prostate Cancer Based on Pretreatment Serum Prostate Specific Antigen LevelsJournal of Urology, 1997
- Radiotherapy for High Grade Clinically Localized Adenocarcinoma of the ProstateJournal of Urology, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Laparoscopic Pelvic Lymph Node Dissection Combined with Real-time Interactive Transrectal Ultrasound Guided Transperineal Radioactive Seed Implantation of the ProstateJournal of Urology, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958